There’s been a noticeable rise in media and public interest in ADHD in recent years. A 2024 YouGov…
Blog
What the NHS ADHD Taskforce report means for clinicians
Summary – What clinicians need to know The NHS England ADHD Taskforce has released its Interim Report on…
DSM-5 and ADHD: What changed, what’s missing, and what clinicians must know
The Diagnostic and Statistical Manual of Mental Disorders (DSM) was first introduced in the 1950s. It went through…
What does the gold standard of ADHD diagnosis and treatment look like in 2025 and beyond?
In 2025, the gold standard of ADHD diagnosis and treatment is evolving, shaped by updated DSM-5 criteria, new…
CHIRP model’s objective technology (QbCheck) improves ADHD pathway efficiency in New Zealand
QbCheck’s objective ADHD testing solutions land in New Zealand. The CHIRP model (combining paediatrics, child development services and…
ADHD vs Autism in clinic settings: red flags and co-diagnosis tips
More than half of adults with ADHD also live with another mental health condition, and almost 40%…
How objective ADHD technology is reducing uncertainty and creating efficiency
ADHD is one of the most prevalent neurodevelopmental disorders, but access to timely and efficient treatment continues to…
What is the future of ADHD care? Recap of the 2025 ADHD Expert Consortium meeting
Each year, the ADHD Expert Consortium meets to review progress and identify new strategies to address gaps in…
Helping teachers understand ADHD: A resource toolkit for schools
Supporting students with ADHD is one of the most common yet complex challenges teachers face in today’s classrooms….
Can objective testing improve ADHD patient outcomes?
The US healthcare system is shifting away from volume-driven visits and tests, and toward value-based care, also…
